STOCK TITAN

Haleon buys back 11M shares November 9–13, 2026

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Haleon plc (HLN) purchased 11,006,678 ordinary shares to hold as treasury shares from November 9 through November 13, 2026, under its buyback programme announced October 29, 2026. The purchases were reported on the London Stock Exchange. Daily volume-weighted average prices were 335.08p on November 9, 334.27p on November 10, 337.53p on November 11, 343.06p on November 12 and 343.10p on November 13.

Filing Explained

Following settlement, Haleon reports registered share capital of 8,808,341,409 ordinary shares, including 39,812,973 held in treasury, leaving 8,768,528,436 shares with voting rights. The company says shareholders may use that voting-rights count to determine whether they must notify it of an interest or a change.

Shares purchased 11,006,678 ordinary shares Purchased November 9–13, 2026, to be held as treasury shares
Volume-weighted average price 335.08p per share Purchases on November 9, 2026
Volume-weighted average price 334.27p per share Purchases on November 10, 2026
Volume-weighted average price 337.53p per share Purchases on November 11, 2026
Volume-weighted average price 343.06p per share Purchases on November 12, 2026
Volume-weighted average price 343.10p per share Purchases on November 13, 2026
Shares with voting rights 8,768,528,436 ordinary shares Following settlement of the purchases
Treasury shares 39,812,973 ordinary shares Following settlement of the purchases
treasury shares financial
"to be held as treasury shares"
Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.
volume weighted average price financial
"Volume weighted average price paid per Share"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.
registered share capital financial
"the Company's registered share capital"
Disclosure Guidance and Transparency Rules regulatory
"FCA's Disclosure Guidance and Transparency Rules"
Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.
Market Abuse Regulation regulatory
"the Market Abuse Regulation"
Market abuse regulation consists of laws and rules designed to prevent dishonest or manipulative practices in financial markets. It aims to ensure fair and transparent trading, so investors can trust that markets operate honestly, much like rules that keep a game fair. By reducing unfair advantages, it helps protect investor confidence and promotes healthy, efficient markets.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did HLN buy back?

Haleon purchased 11,006,678 ordinary shares to be held as treasury shares under the buyback programme announced October 29, 2026. Purchases covered November 9 through November 13, 2026.

What were the daily average prices for HLN's share purchases?

The reported daily volume-weighted average prices were 335.08p on November 9, 334.27p on November 10, 337.53p on November 11, 343.06p on November 12 and 343.10p on November 13, 2026.

How many HLN shares had voting rights after settlement?

After settlement, 8,768,528,436 ordinary shares had voting rights. Haleon said shareholders may use this figure to determine whether they are required to notify an interest, or a change to an interest, under the FCA's Disclosure Guidance and Transparency Rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F ☒
 
Form 40-F ☐
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
16 November 2026 - “Transactions in Own Shares”
  
99.1
 
 
Haleon plc: Aggregated information - transactions in own shares
 
16 November 2026: Haleon plc (the “Company” or “Haleon”) today announces the purchase of 11,006,678 ordinary shares of £0.01 each in the Company (the “Shares”) to be held as treasury shares under its share buyback programme announced on 29 October 2026.
 
 
London Stock Exchange
 
CBOE (UK)/BXE
 
CBOE (UK)/CXE
 
Aquis
 
Date of purchase:
 
09 November 2026
 
Number of Shares purchased:
 
2,777,756
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
341.00p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
331.90p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
335.08p
 
-
 
-
 
-
 
Date of purchase:
 
10 November 2026
 
Number of Shares purchased:
 
2,542,718
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
337.70p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
330.00p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
334.27p
 
-
 
-
 
-
 
Date of purchase:
 
11 November 2026
 
Number of Shares purchased:
 
1,816,227
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
339.90p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
333.90p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
337.53p
 
-
 
-
 
-
 
Date of purchase:
 
12 November 2026
 
Number of Shares purchased:
 
1,613,684
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
344.60p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
341.10p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
343.06p
 
-
 
-
 
-
 
Date of purchase:
 
13 November 2026
 
Number of Shares purchased:
 
2,256,293
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
346.00p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
340.50p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
343.10p
 
-
 
-
 
-
 
 
Following the settlement of the above, the Company's registered share capital is 8,808,341,409 ordinary shares of £0.01 each, of which 39,812,973 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,768,528,436 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/1945D_1-2026-11-13.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com. 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: November 16, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

Keep reading